ANNE LAM to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications ANNE LAM has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.344
-
Propensity score matching analysis to evaluate the comparative effectiveness of daratumumab versus real-world standard of care therapies for patients with heavily pretreated and refractory multiple myeloma. Leuk Lymphoma. 2019 01; 60(1):163-171.
Score: 0.344